Search Results

Keywords: epidiolex

Merrill Lynch launches marijuana sector coverage, predicts more cross-border deals

April 22, 2019 · Updated August 15, 2019

Bank of America Merrill Lynch deepened its interest in the cannabis industry by initiating coverage of the burgeoning sector, less than a year after it financed Constellation’s multibillion-dollar investment in Canada’s Canopy Growth. The report, by analyst Chris Carey, predicts two events may lead to a paradigm shift: Canada reaching marijuana oversupply by 2021. U.S. legalization. “Importantly, whether […]

Read More

South Korea’s medical marijuana law to go into effect in March

February 19, 2019 · Updated May 6, 2019

A groundbreaking law legalizing medical cannabis in South Korea that takes effect March 12 will pave the way for the first import of certain THC- and CBD-based medications. Although approved products will remain tightly restricted, the new law marks a significant milestone in the global industry and a turning point in how the drug is perceived in […]

Read More

What is ‘marijuana’? Name game limits cannabis entrepreneurs

December 7, 2018

The old debate about what to call the plant cannabis sativa L. is giving businesses real-world headaches in both new and established marijuana markets. Consider: Iowa allows medical marijuana but calls it something else. Texas restricts medical marijuana so severely that doctors must break the law to use the state’s program. California officials are struggling […]

Read More

Connecticut adds another condition to medical marijuana treatment list

November 12, 2018

Connecticut regulators added another ailment to the list of conditions that can be treated with medical cannabis, bringing the total number of conditions to 31 for adults. The state’s Regulations Review Committee decided chronic neuropathic pain associated with degenerative spinal disorders should be included on the list. The added condition could provide a slight boost to […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

October 16, 2018 · Updated August 15, 2019

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More

CBD drugmaker GW Pharmaceuticals poised to raise $300 million

October 2, 2018 · Updated August 15, 2019

GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals to treat rare […]

Read More

FDA: CBD shouldn’t be a controlled substance, but treaties require it

October 1, 2018

The U.S. Food and Drug Administration noted that cannabidiol shouldn’t be a controlled substance, but international treaties require the United States to treat it as one, the federal agency said in a 27-page memo written after it approved the first drug made with CBD earlier this year. “CBD has negligible potential for abuse,” wrote Dr. Brett Giroir, the assistant […]

Read More

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

September 27, 2018 · Updated May 20, 2019

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

It’s a decision that immediately affects CBD producers but also signals the agency’s first admission that the plant has medical value.

Read More

‘Breakthrough’ in South Korea as cannabis law gets major backer

July 24, 2018

A move to legalize medical marijuana in South Korea picked up a key backer, increasing its chances of approval by the end of this year. South Korea would be the only country in Asia, besides Israel, to approve medical cannabis for qualifying patients, which would mark a significant milestone in the global medical cannabis industry. India […]

Read More